ReviewTherapeutic advances in gastroenterology2026
The GETAID: over 40 years of academic research in IBD.
Review in Therapeutic advances in gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Founded in 1983 in Paris by Professor R. Modigliani, the Groupe d'ETude des Affections Inflammatoires Digestives (GETAID) was established to develop collaborative clinical research on inflammatory bowel disease (IBD). This was innovative 40 years ago and remains challenging today. From the beginning, this multicenter group has aimed to address clinical questions arising from patients, physicians, and the IBD community by conducting clinical research on treatments through randomized controlled trials, prospective cohorts, index creation, and observational studies. GETAID has advanced IBD knowledge by publishing over 140 original articles in peer-reviewed journals. This review explores the history of the GETAID, how it functions, and its contribution to IBD knowledge over the past four decades. It illustrates the disruptive and innovative academic research conducted by an independent group of researchers and its potential future impact through examples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.